198 related articles for article (PubMed ID: 12854173)
1. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
Xing Y; Ning Y; Ru LQ; Wang LD
World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
[TBL] [Abstract][Full Text] [Related]
2. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL
World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
[TBL] [Abstract][Full Text] [Related]
3. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Wang LD; Zhou Q; Yang CS
J Cell Biochem Suppl; 1997; 28-29():159-65. PubMed ID: 9589362
[TBL] [Abstract][Full Text] [Related]
4. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China.
Dong Wang L; Bin Yue W; Zhou Y; Wei Feng C; Liu B; Zhou Q; Ying Jia Y; Zheng S; Gao SS; Ji Xie X; Min Fan Z; Min Niou H; Hao Zhuang Z; Yang CS; Min Bai Y; Jun Qi Y
Dis Esophagus; 2002; 15(1):80-4. PubMed ID: 12060048
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus; a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus.
Okudela K; Ito T; Kameda Y; Nakamura N; Kitamura H
Histol Histopathol; 1999 Apr; 14(2):479-85. PubMed ID: 10212809
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China.
Yang G; Zhang Z; Liao J; Seril D; Wang L; Goldstein S; Yang CS
Int J Cancer; 1997 Sep; 72(5):746-51. PubMed ID: 9311588
[TBL] [Abstract][Full Text] [Related]
8. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
9. Changes in p53 and Waf1p21 expression and cell proliferation in esophageal carcinogenesis.
Wang LD; Yang WC; Zhou Q; Xing Y; Jia YY; Zhao X
World J Gastroenterol; 1997 Jun; 3(2):87-9. PubMed ID: 27041952
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus.
Fujii T; Nakagawa S; Hanzawa M; Sueyoshi S; Fujita H; Shirouzu K; Yamana H
Oncol Rep; 2003; 10(2):427-31. PubMed ID: 12579284
[TBL] [Abstract][Full Text] [Related]
12. Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients.
Ueno H; Hirai T; Nishimoto N; Hihara J; Inoue H; Yoshida K; Yamashita Y; Toge T; Tsubota N
J Exp Clin Cancer Res; 2003 Jun; 22(2):239-45. PubMed ID: 12866574
[TBL] [Abstract][Full Text] [Related]
13. Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia.
Shirakawa Y; Naomoto Y; Kimura M; Kawashima R; Yamatsuji T; Tamaki T; Hamada M; Haisa M; Tanaka N
Clin Cancer Res; 2000 Feb; 6(2):541-50. PubMed ID: 10690537
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection.
Hasegawa M; Ohoka I; Yamazaki K; Hanami K; Sugano I; Nagao T; Asoh A; Wada N; Nagao K; Ishida Y
Pathol Int; 2002 Jul; 52(7):442-50. PubMed ID: 12167102
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
Lam KY; Law S; Tin L; Tung PH; Wong J
Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
[TBL] [Abstract][Full Text] [Related]
16. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.
Wang LD; Yang HH; Fan ZM; Lü XD; Wang JK; Liu XL; Sun Z; Jiang YN; He X; Zhou Q
Cancer Detect Prev; 2005; 29(4):317-22. PubMed ID: 16118042
[TBL] [Abstract][Full Text] [Related]
17. Alterations in p53 expression and cell proliferation in esophageal epithelia among patients from geographical areas with high or low incidence of esophageal cancer.
Wang LD; Zhou Q; Zhang YC; Li XF; Wang WP; He L; Gao SS; Li YX
World J Gastroenterol; 1997 Jun; 3(2):80. PubMed ID: 27041947
[TBL] [Abstract][Full Text] [Related]
18. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
